Yong Ben - May 30, 2025 Form 4 Insider Report for Corbus Pharmaceuticals Holdings, Inc. (CRBP)

Role: Director
Signature: /s/ Meghan Houghton, attorney-in-fact for Yong Ben
Stock symbol: CRBP
Transactions as of: May 30, 2025
Transactions value $: $0
Form type: 4
Date filed: 6/2/2025, 04:30 PM
Previous filing: Jun 3, 2024
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Ben Yong	Director	C/O CORBUS PHARMACEUTICALS HOLDINGS, INC, 500 RIVER RIDGE DRIVE, NORWOOD	/s/ Meghan Houghton, attorney-in-fact for Yong Ben	2025-06-02	0001967669

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CRBP	Common Stock, par value $0.0001 per share	Award	$0	+4.8K	+172.48%	$0.00	7.58K	May 30, 2025	Direct	F1, F2

Showing 1 to 1 of 1 entries

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CRBP	Stock options (right to buy)	Award	$0	+16K		$0.00	16K	May 30, 2025	Common Stock	16K	$7.42	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On May 30, 2025, 4,800 restricted stock units ("RSUs") were granted, which will be settled in shares of common stock, par value $0.0001. The RSUs will vest 100% on the one-year anniversary from the date of grant.
F2	This amount includes 4,800 unvested RSUs that were granted on May 30, 2025.
F3	The option award was made in accordance with the terms of the issuer's 2024 Equity Compensation Plan. The option will vest 100% on the one-year anniversary from the date of grant.